A retrospective case series of Fournier’s gangrene: necrotizing fasciitis in perineum and perianal region

Springer Science and Business Media LLC - 2020
Nan Zhang1, Xin Yu2, Kai Zhang1, Tongjun Liu1
1General Surgery, Jilin University Second Hospital, Changchun, China
2Department of Pediatrics, Jilin University First Hospital, Changchun, China

Tóm tắt

To describe the clinical characteristics and management for Fournier’s gangrene. Experience summary and literature references are provided for future treatment improvement. We retrospectively reviewed the cases diagnosed with Fournier’s gangrene in our department from June 2016 to June 2019. Clinical data, including manifestation, diagnosis, treatment and outcomes for Fournier’s gangrene were presented. There were 12 patients enrolled in this paper, with the average age of 60 years old. It showed a male predominance with male-to-female ratio of 6:1. The average of laboratory risk indicator for necrotizing fasciitis (LRINEC) score was 10.1. Diabetes mellitus was the main predisposing disease. 11 patients received emergency debridement and 1 patient died of sepsis on the 2nd day after admission. The mortality rate was 8.3%. 6 cases developed complications, including sepsis, pneumonia, renal and heart failure. Negative pressure wound therapy (NPWT) was applied in 10 cases, while the rest 1 received normal daily dressing changes because of fecal contamination. Flaps were utilized in 2 patients to cover the defect, including one with advancement flap and one with pudendal-thigh flap, while others received secondary suture, secondary healing, skin graft or combined management. No relapse was observed during the follow-up visits. Fournier’s gangrene is a life-threatening infection that requires early diagnosis and surgery intervention. The predisposing disease, clinical manifestation and LRINEC score should be taken into comprehensive consideration, which is helpful for timely diagnosis. Moreover, further successful treatment depends on the aggressive debridement, broad-spectrum antibiotics therapy, wound management and closure choice.

Từ khóa


Tài liệu tham khảo

Aridogan IA, Izol V, Abat D, Karsli O, Bayazit Y, Satar N. Epidemiological characteristics of Fournier’s gangrene: a report of 71 patients. Urol Int. 2012;89(4):457–61.

Villanueva-Sáenz E, Martínez Hernández-Magro P, Valdés Ovalle M, Montes Vega J, Alvarez-Tostado FJ. Experience in management of Fournier’s gangrene. Tech Coloproctol. 2002;6(1):5–13.

Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD, Wessells H. Fournier’s Gangrene: population based epidemiology and outcomes. J Urol. 2009;181(5):2120–6.

Wong C, Khin L, Heng K, Tan K, Low C. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–41.

Martinez-Rodriguez R, Ponce de Leon J, Caparros J, Villavicencio H. Fournier’s gangrene: a monographic urology center experience with twenty patients. Urol Int. 2009;83(3):323–8.

Tang LM, Su YJ, Lai YC. The evaluation of microbiology and prognosis of fournier’s gangrene in past five years. Springerplus. 2015;4:14.

Czymek R, Hildebrand P, Kleemann M, Roblick U, Hoffmann M, Jungbluth T, Bürk C, Bruch HP, Kujath P. New insights into the epidemiology and etiology of Fournier’s gangrene: a review of 33 patients. Infection. 2009;37(4):306–12.

Safioleas M, Stamatakos M, Mouzopoulos G, Diab A, Kontzoglou K, Papachristodoulou A. Fournier’s gangrene: exists and it is still lethal. Int Urol Nephrol. 2006;38(3–4):653–7.

Wróblewska M, Kuzaka B, Borkowski T, Kuzaka P, Radziszewski P. Fournier’s gangrene—current concepts. Pol J Microbiol. 2014;63(3):267–73.

Mehmet U, Ercan G, Sadullah G, Celen MK, Celal A. The evaluation of microbiology and Fournier’s gangrene severity index in 27 patients. Int J Infect Dis. 2009;13(6):e424-430.

Nisbet AA, Thompson IM. Impact of diabetes mellitus on the presentation and outcomes of Fournier’s gangrene. Urology. 2002;60(5):775–9.

Singh A, Ahmed K, Aydin A, Khan MS, Dasgupta P. Fournier’s gangrene. A clinical review. Arch Ital Urol Androl. 2016;88(3):157–64.

Landau Z, Raz I, Wainstein J, Bar-Dayan Y, Cahn A. The role of insulin pump therapy for type 2 diabetes mellitus. Diabetes Metab Res Rev. 2017;33(1):e2822.

Chen SY, Fu JP, Wang CH, Lee TP, Chen SG. Fournier gangrene: a review of 41 patients and strategies for reconstruction. Ann Plast Surg. 2010;64(6):765–9.

Ioannidis O, Kitsikosta L, Tatsis D, Skandalos I, Cheva A, Gkioti A, Varnalidis I, Symeonidis S, Savvala NA, Parpoudi S, et al. Fournier’s gangrene: lessons learned from multimodal and multidisciplinary management of perineal necrotizing fasciitis. Front Surg. 2017;4:36.

Chawla SN, Gallop C, Mydlo JH. Fournier’s gangrene: an analysis of repeated surgical debridement. Eur Urol. 2003;43(5):572–5.

Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS. Fournier’s gangrene: current practices. ISRN Surg. 2012;2012:942437.

Burner E, Henderson S, Burke G, Nakashioya J, Hoffman JR. Inadequate sensitivity of laboratory risk indicator to rule out necrotizing fasciitis in the emergency department. West J Emerg Med. 2016;17(3):333–6.

Assenza M, Cozza V, Sacco E, Clementi I, Modini C. VAC (vacuum assisted closure) treatment in Fournier’s gangrene: personal experience and literature review. Clin Ter. 2011;162(1):e1-5.

Insua-Pereira I, Ferreira PC, Teixeira S, Barreiro D, Silva A. Fournier’s gangrene: a review of reconstructive options. Cent Eur J Urol. 2020;73(1):74–9.

Levett D, Bennett M, Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis. Cochrane Database Syst Rev. 2015;1:CD007937.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả